UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

Scientific reports, 2020-02, Vol.10 (1), p.2765-2765, Article 2765

2020

Volltextzugriff (PDF)

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

International journal of clinical practice (Esher), 2011-04, Vol.65 (4), p.397-407

2011

Volltextzugriff (PDF)

Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents

Diabetes, obesity & metabolism, 2012-04, Vol.14 (s2), p.20-32

2012

Volltextzugriff (PDF)

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

Scientific reports, 2021-08, Vol.11 (1), p.16453-16453, Article 16453

2021

Volltextzugriff (PDF)

Hemorragia adrenal bilateral metacrónica en el síndrome antifosfolipídico primario

Medicina clínica, 2017, Vol.149 (7), p.318-318

2017

Volltextzugriff (PDF)

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme

Diabetes, obesity & metabolism, 2016-07, Vol.18 (7), p.707-710

2016

Volltextzugriff (PDF)

Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy

Diabetes (New York, N.Y.), 2000-08, Vol.49 (8), p.1341-1346

2000

Volltextzugriff (PDF)

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial

NPJ digital medicine, 2021-09, Vol.4 (1), p.138-138, Article 138

2021

Volltextzugriff (PDF)

Relevancia de las características del inmunoanálisis para insulina en la hipoglucemia facticia

Endocrinología, diabetes y nutrición, 2018, Vol.65 (5), p.306-307

2018

Volltextzugriff (PDF)

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

The Lancet (British edition), 2009-07, Vol.374 (9683), p.39-47

2009

Volltextzugriff (PDF)

Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome

Diabetologia, 2007-03, Vol.50 (3), p.602-611

2007

Volltextzugriff (PDF)

Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease

Acta neurochirurgica, 2007-05, Vol.149 (5), p.471-479

2007

Volltextzugriff (PDF)

Rationale and study design of the RESERVOIR trial: A randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus

Catheterization and cardiovascular interventions, 2015-03, Vol.85 (4), p.E116-E122

2015

Volltextzugriff (PDF)

Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index)

Acta diabetologica, 2013-08, Vol.50 (4), p.529-535

2013

Volltextzugriff (PDF)

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

The Lancet (British edition), 2010-04, Vol.375 (9724), p.1447-1456

2010

Volltextzugriff (PDF)

Adenoviral overexpression of interleukin-1 receptor antagonist protein increases β-cell replication in rat pancreatic islets

Gene therapy, 2005-01, Vol.12 (2), p.120-128

2005

Volltextzugriff (PDF)

Patients likelierto reach A1c target during 26 weeks’ treatment with liraglutide compared with sitagliptin or exenatide

Primary care diabetes, 2013-04, Vol.7 (1), p.89-89

2013

Volltextzugriff (PDF)

Cacería de subsistencia de distintos grupos indígenas de la Amazonía ecuatoriana

Ecosistemas revista científica y técnica de ecología y medio ambiente, 2013-05, Vol.22 (2), p.84-96

E. de la Montaña

2013

Volltextzugriff (PDF)

In T2D patients with baseline A1c <8.0%, liraglutide achieves A1c targets more often than sitagliptin or exenatide

Primary care diabetes, 2013-04, Vol.7 (1), p.79-79

2013

Volltextzugriff (PDF)

P279 - Liraglutide réduit plus efficacement l’HbA1c que la Sitagliptine quel que soit le niveau d’HbA1c initial

Diabetes & metabolism, 2011, Vol.37 (1), p.A99-A99

2011

Volltextzugriff (PDF)

Islet- and stem-cell-based tissue engineering in diabetes

Current opinion in biotechnology, 2004-10, Vol.15 (5), p.435-440

Montanya, Eduard

2004

Volltextzugriff (PDF)

Optimization of Human Pancreatic Islet Isolation With a Newly Designed Cooling System for COBE 2991

Transplantation proceedings, 2009-07, Vol.41 (6), p.2202-2203

2009

Volltextzugriff (PDF)

β-Cell Death and Mass in Syngeneically Transplanted Islets Exposed to Short- and Long-Term Hyperglycemia

Diabetes (New York, N.Y.), 2002-01, Vol.51 (1), p.66-72

2002

Volltextzugriff (PDF)

Abstract 25: Glycemic variability of oral semaglutide versus empagliflozin: A post hoc analysis of PIONEER 2

Indian journal of endocrinology and metabolism, 2022-03, Vol.26 (Suppl 1), p.S14-S15

2022

Volltextzugriff (PDF)

Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors

Acta diabetologica, 2005-06, Vol.42 (2), p.87-94

2005

Volltextzugriff (PDF)

1 – 25 von 916

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(536)
Mit Volltextzugriff
(665)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(83)
Science & Technology
(73)
Life Sciences & Biomedicine
(62)
Male
(51)
Female
(47)
Middle Aged
(32)
Adult
(30)
Biological And Medical Sciences
(29)
Medicine, General & Internal
(26)
Diabetes
(25)
Medical Sciences
(24)
Endocrinology & Metabolism
(23)
Animals
(21)
Aged
(16)
Endocrinopathies
(16)
Internal Medicine
(16)
Endocrine Pancreas. Apud Cells
(15)
General & Internal Medicine
(15)
Blood Glucose - Metabolism
(14)
Diabetes. Impaired Glucose Tolerance
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(11)
... seit 90 Tagen
(31)

Menü

Weitere Dienste

Einstellungen

Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial

Comparison of liraglutide versus other incretin-related anti-hyperglycaemic agents

Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

Hemorragia adrenal bilateral metacrónica en el síndrome antifosfolipídico primario

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme

Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: role of beta-cell hyperplasia and hypertrophy

Digital intervention increases influenza vaccination rates for people with diabetes in a decentralized randomized trial

Relevancia de las características del inmunoanálisis para insulina en la hipoglucemia facticia

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)

Adenoviral overproduction of interleukin-1 receptor antagonist increases beta cell replication and mass in syngeneically transplanted islets, and improves metabolic outcome

Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease

Rationale and study design of the RESERVOIR trial: A randomized trial comparing reservoir-based polymer-free amphilimus-eluting stents versus everolimus-eluting stents with durable polymer in patients with diabetes mellitus

Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index)

Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial

Adenoviral overexpression of interleukin-1 receptor antagonist protein increases β-cell replication in rat pancreatic islets

Patients likelierto reach A1c target during 26 weeks’ treatment with liraglutide compared with sitagliptin or exenatide

Cacería de subsistencia de distintos grupos indígenas de la Amazonía ecuatoriana

In T2D patients with baseline A1c <8.0%, liraglutide achieves A1c targets more often than sitagliptin or exenatide

P279 - Liraglutide réduit plus efficacement l’HbA1c que la Sitagliptine quel que soit le niveau d’HbA1c initial

Islet- and stem-cell-based tissue engineering in diabetes

Optimization of Human Pancreatic Islet Isolation With a Newly Designed Cooling System for COBE 2991

β-Cell Death and Mass in Syngeneically Transplanted Islets Exposed to Short- and Long-Term Hyperglycemia

Abstract 25: Glycemic variability of oral semaglutide versus empagliflozin: A post hoc analysis of PIONEER 2

Regression of microalbuminuria in type 1 diabetic patients: results of a sequential intervention with improved metabolic control and ACE inhibitors

Suchergebnisse filtern